Pharma & Bio
Lifestyle
HK InnoN K-Cap: Three Reasons for Its Competitiveness in China, the Battleground for P-CABs
HK InnoN’s new drug “K-Cap” for gastroesophageal reflux disease (GERD) has begun to gain significant market share in China and has entered a phase of generating royalty revenue. Unlike Takeda Pharmace…
Technology
Kim Hyung-jun, CEO of Able Therapeutics: “Early Detection of Dementia Through Voice… AI Picks It Up”
(Graphic: Generative AI)
“Roses have bloomed in the garden.”Kim Hyung-jun, CEO of Able Therapeutics, recently met with E-Daily’s pharmaceutical and biotech premium content service, Pharm E-Daily, …
Technology
"After Oral Drugs, Next Up Are Indications"... A Look at Novo and Lilly's Next-Generation Pipelines
As the first round of the “weight-loss drug war” between Eli Lilly and Novo Nordisk effectively tilts in Lilly’s favor, the two pharmaceutical giants have entered a high-stakes second round, competing…
Technology
DRTech, TissueGene, and Finemedix All Rally [K-bio Pulse]
On the 13th, three companies in Korea’s pharmaceutical, biotech, and healthcare sectors—#DRTech, #KolonTissueGene, and #FinemediX—all posted gains. DR Tech and FinemediX rose on the back of improved e…
Technology
[Bio Spotlight] DRTECH Corporation Soars to Daily Limit Up… Kolon TissueGene, Inc. Also Rebounds Slightly
On the 13th, in the domestic pharmaceutical, biotech, and healthcare sectors, DRTECH Corporation(214680) Kolon TissueGene, Inc.(950160) #Finemedix Co., Ltd. all posted gains. DRTECH Corporation and Fi…
Technology
Royvant Bets on Hanol’s IMVT-1402… “GD New Drug to Launch Ahead of Competitors”
Royvant is focusing its funding and development capabilities on IMVT-1402 (active ingredient: imeropruvate), a next-generation FcRn antibody licensed from HANALL BIOPHARMA CO.,LTD(009420). This comes …
Lifestyle
JW Pharma Jumps 15%, OliX Sinks 14% on Overhang Concerns [K-Bio Pulse]
South Korean pharmaceutical and biotech stocks traded lower across the board, with #JW Pharmaceutical and #OliX Pharmaceuticals drawing particular attention. JW Pharmaceutical surged nearly 15% as suc…
Lifestyle
JWPHARMACEUTICAL Jumps 16% on Phase 3 Success... Why Did 'Positive News' Olix Pharmaceuticals, Inc. Plunge 11%? [Bio Spotlight]
While domestic pharmaceutical and biotech stocks were generally weak, JWPHARMACEUTICAL(001060)and Olix Pharmaceuticals, Inc.(226950)drew attention. JWPHARMACEUTICAL surged more than 16% as the success…
Technology
Korean Dental Stocks Rally on M&A and Strong Earnings [K-Bio Pulse]
Shares of dental-related companies rallied in South Korea’s pharmaceutical, biotech, and healthcare market on Aug. 11, buoyed by expectations for business expansion and strong earnings.South Korea’s d…
Technology
Graphy Inc., Backed by Ray Co., Ltd.; Value Added Technology Co., Ltd. Posts Surprise Earnings… K-Dental Stocks Rise in Tandem [Bio Spotlight]
On the 11th, stock prices of listed companies in the dental sector rose across the board in the domestic pharmaceutical, biotech, and healthcare market. The domestic dental industry has established a …